Antalgic effects of strontium-89 therapy on bone metastases in 65 patients with lung cancer

Chinese Journal of Clinical Rehabilitation

Volumn 8, Issue 5, 2004, Pages 812-813

  Fan, Yi Xiang ^a   Luo, Rong Cheng ^a   Li, Gui Ping ^a   Huang, Kai ^a  

^a FIRST MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; NEURON SPECIFIC ENOLASE; STRONTIUM 89;

ADULT; AGED; ANALGESIA; ARTICLE; BLOOD ANALYSIS; BONE METASTASIS; BONE PAIN; BONE SCINTISCANNING; CANCER PATIENT; DRUG EFFICACY; FEMALE; HUMAN; LEUKOCYTE COUNT; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PAIN ASSESSMENT; QUALITY OF LIFE; SCORING SYSTEM; SIDE EFFECT; THROMBOCYTE; THROMBOCYTE COUNT; TREATMENT OUTCOME;

EID: 2442459844     PISSN: 16715926     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Chinese source. 2001, 4(2): 109-11
2. Chinese source. 2001, 21(1): 61-2
3. Mcewan AJ. Use of radionuclide for the palliation of bone metastases. Semin Radiat Oncol 2000; 10(2): 103-14
4. Chinese source. 2002, 6(18): 2821
5. Chinese source. 2003, 7(2): 4419
6. Chinese source. 2002, 69(10): 1465